CYCLOPHENE

Manufacturer
California Pharmaceuticals LLC
Effective date
2016-07-25
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 20:22:32

Label at a glance#

ProductCYCLOPHENE
Active ingredientCYCLOBENZAPRINE HYDROCHLORIDE
Label structure4 sections

Label contents#

Full prescribing information#

Instructions for PharmacistPage 1Page 2

INSTRUCTIONS FOR USE SECTION

NDC 70332-102-01

For Prescription Compounding Only

Rx only


RapidPaq™
CYCLOPHENE™
(5% cyclobenzaprine hydrochloride topical cream kit)

RapidPaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).

Description:
This kit contains active and inactive materials to prepare approximately 111.2 grams of Cyclobenzaprine Hydrochloride topical cream. This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.

Active Ingredients:
- 5.6 g Cyclobenzaprine Hydrochloride [equivalent to 4.9 g Cyclobenzaprine]

Inactive Ingredients:
- 100 g RapidPaq Cream Base (D. l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexylglycerin,
Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA)
- 5.6 Ethoxy Diglycol
- Spatula
- Instructions

Pharmacist Instructions for Preparation

1 Remove and Inspect the Contents of the Kit

Ensure that all components are present. Ensure that the safety seals are present on the Cyclobenzaprine Hydrochloride, ethoxy diglycol and RapidPaq Cream Base. If components are missing or the safety seals are not intact do not use the kit.

2 Prepare for Mixing

Wear gloves and eye protection during mixing operations. Remove the cap and seal from the RapidPaq Cream Base. Break the perforated seal and remove the cap from the Cyclobenzaprine Hydrochloride and ethoxy diglycol.

3 Dissolve the Cyclobenzaprine Hydrochloride

Using a spatula make a well in the center of the RapidPaq Cream Base. Transfer approximately half of the ethoxy diglycol to the Cyclobenzaprine Hydrochloride bottle. Cap the Cyclobenzaprine Hydrochloride bottle and shake to ensure that all residue Cyclobenzaprine Hydrochloride has been dissolved. Pour the contents into the RapidPaq Cream Base. Repeat this step with the remaining ethoxy diglycol.

4 Complete the Mixing Process

Using the spatula, mix the RapidPaq Base jar that now contains the ethoxy diglycol and cyclobenazprine hydrochloride ingredients thoroughly for about 2 minutes or until fully dissolved.

5 Relabel the Resulting Cream

Label the resulting topical cream as required for prescription products. Ensure that the original RapidPaq Cream Base label is removed or obscured, since the original label is no longer accurate once the cream is prepared.

Discard the spatula.

Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the topical cream between 15-30°C (59-86°F). The final cream is stable for up to eight weeks.

U.S. Patents Pending

Repackaged and Distributed by:
California Pharmaceuticals, LLC
768 Calle Plano
Camarillo, CA 93012

California
PHARMACEUTICALS LLC

CS107-A1 rev 3

Cyclophene instructionsCyclophene instructions

Cyclophene instructionsCyclophene instructions

Cyclobenzaprine Hydrochloride product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Do not use if saety seal is broken

Cyclobenzaprine Hydrochloride

1-propanamine, 3-(5H-dibenzo[a,d]cycloheptenn-5-ylidene)-N,N-dimethyl-, hydrochloride

RxOnly

CAS # 6202-23-9

Net contents 5.6 g

Repackaged by:

California Pharmaceuticals, LLC

Camarillo, CA 93012

California

PHARMACEUTICALS LLC

CS104-A1 rev 1

Cyclobenzaprine labelCyclobenzaprine label

RapidPaq Cream Base product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Do not use if seal is broken

RapidPaq™ Cream base

Net contents: 100 g

Ingredients: (D.l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexylglycerin, Tocopheryl Acetate,

Aloe barbadensis, Disodium EDTA.)

RX Only

Manufactured for California Pharmaceyticals, LLC, Camarillo, CA 93012

RapidPaq Cream BaseRapidPaq Cream Base

CYCLOPHENE Kit product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70332-102-01

Rx only

RapidPaq™

Kit for Topical Cream

CYCLOPHENE™

(5% cyclobenzaprine hydrochloride topical cream kit)

Muscle relaxant

Store at room temperature,

15-30°C (59-86°F)

Description:

This kit contains active and inactive materials to prepare approximately 111.2 grams of Cyclobenzaprine Hydrochloride topical cream. This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.

Active ingredient

- 5.6 g Cyclobenzaprine Hydrochloride USP [equivalent to 4.9 g Cyclobenzaprine]

Inactive Ingredients:

   - 100 g RapidPaq Cream Base(D.l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and) ethylhexylglycerin,

                                                Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA)

   - 5.6 g Ethoxy Diglycol

   - Spatula

   - Instructions

U.S. Patents Pending

Do not use if safety seal is broken

California

PHARMACEUTICALS LLC

Repacked and Distributed By;

Caifornis Pharmaceuticals, LLC

768 Calle Plano

Camarillo, CA 93012

CS 108-A1 rev 1

Cyclophene KitCyclophene Kit

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CYCLOBENZAPRINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
51048710-225c-aa41-d0e7-eed095d02838Product name420250331
6084a4f4-5437-c9a5-caec-5361ee075a59Product name120140508
90c5639a-61b0-88d6-ddcf-21888e94869aProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
c2c26dc9-7e16-fc02-7eba-6b46ed3515eeProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70332-102-012020-01-31C16284748780-19d75b9d0-4ca5-f424-e053-dadaa90a57ceCYCLOPHENE - 70332-102

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70332-102-01CYCLOPHENE1 in 1 KITKIT14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70332-102CYCLOPHENE KIT [CALIFORNIA PHARMACEUTICALS LLC]4Legacy NDC, 1 package rows20160725_26533d10-58da-6752-e054-00144ff8d46c.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70332-102-01GM - Gram70332-1028e471260-d37a-4105-be71-39e7329a8a6012016-09-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70332-10270332-102-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
99221323-f45d-4d12-abe4-0114ea75c18726533d10-58da-6752-e054-00144ff8d46c2016-07-25Exact identifier
spl id: 99221323-f45d-4d12-abe4-0114ea75c187
spl set id: 26533d10-58da-6752-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.